
iFAST
Operator of a medical research company intended to reduce the threat of antimicrobial resistance. The company facilitates antimicrobial susceptibility test systems to avoid the growth of bacteria in t...
Valuation
$16.4M
Latest known
Share Price
N/A
Total Raised
$8.9M
Last Round
N/A